SCHEMBL4190794

SCHEMBL4190794

O=Cc1ccc2cc(O)ccc2c1O

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.44
ESR2 Q92731 5/20 0.44
ERN1 O75460 4/20 0.39
CYP1A2 P05177 1/20 0.39
TRIM24 O15164 1/20 0.38
TYR P14679 1/20 0.38
TRIM33 Q9UPN9 1/20 0.38
KCNJ11 Q14654 1/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
KMT2A Q03164 1/20 0.38
HNF4A P41235 1/20 0.37
CYP3A4 P08684 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10331768 0.86 ESR1 (0.45) ESR1ESR2ERN1TRIM24TYR
SCHEMBL15065087 0.83 ERN1 (0.49) ESR1ESR2ERN1
SCHEMBL15698095 0.81 ERN1 (0.47) ERN1CYP1A2LMNAHSD17B10
SCHEMBL2372753 0.78 ERN1 (0.45) ESR1ESR2ERN1TRIM24TYR
SCHEMBL23061789 0.78 NSD2 (0.43) ERN1HSD17B10
SCHEMBL17654724 0.78 ESR1 (0.49) ESR1ESR2ERN1TRIM24TYR
SCHEMBL12760794 0.78 TRIM24 (0.60) ERN1CYP1A2TRIM24TYRTRIM33
SCHEMBL29956684 0.77 ERN1 (0.44) ESR1ESR2ERN1CYP1A2TRIM24
SCHEMBL3067367 0.77 ERN1 (0.44) ESR1ESR2ERN1CYP1A2TRIM24
SCHEMBL589343 0.76 ERN1 (0.55) ERN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7470821-B2 Aldolase-inhibiting aromatic compounds VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) 2008-12-30 US claimed
EP-1641807-B1 AROMATIC COMPOUNDS AS ALDOLASE INHIBITORS UNIV TOULOUSE (FR) 2008-06-18 EP claimed
JP-2007516184-A 2007-06-21 JP claimed
US-20070043002-A1 Aldolase-inhibiting aromatic compounds UNIVERSITE PAUL SABATIER TOULOUSE III (FR) 2007-02-22 US claimed
EP-1641807-A2 AROMATIC COMPOUNDS AS ALDOLASE INHIBITORS UNIVERSITE PAUL SABATIER TOULOUSE III (FR) 2006-04-05 EP claimed
WO-2005012313-A2 ALDOLASE-INHIBITING AROMATIC COMPOUNDS UNIVERSITE PAUL SABATIER TOULOUSE III (FR) 2005-02-10 WO claimed
EP-2476713-B1 Resist underlayer film composition and patterning process using the same SHINETSU CHEMICAL CO (JP) 2018-04-11 EP disclosed
US-9230827-B2 Method for forming a resist under layer film and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-01-05 US disclosed
US-9230827-B2 Method for forming a resist under layer film and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-01-05 US disclosed
US-9046764-B2 Resist underlayer film composition, method for producing polymer for resist underlayer film, and patterning process using the resist underlayer film composition SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-06-02 US disclosed
US-9046764-B2 Resist underlayer film composition, method for producing polymer for resist underlayer film, and patterning process using the resist underlayer film composition SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-06-02 US disclosed
EP-2816409-A1 Method for forming a resist under layer film and patterning process Shin-Etsu Chemical Co., Ltd. (JP) 2014-12-24 EP disclosed
US-20140335692-A1 METHOD FOR FORMING A RESIST UNDER LAYER FILM AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-11-13 US disclosed
EP-2476713-A1 Resist underlayer film composition and patterning process using the same Shin-Etsu Chemical Co., Ltd. (JP) 2012-07-18 EP disclosed
US-20090137532-A1 Aldolase-inhibiting aromatic compounds VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) 2009-05-28 US disclosed
US-7470821-B2 Aldolase-inhibiting aromatic compounds VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) 2008-12-30 US disclosed
EP-1641807-B1 AROMATIC COMPOUNDS AS ALDOLASE INHIBITORS UNIV TOULOUSE (FR) 2008-06-18 EP disclosed
US-20070043002-A1 Aldolase-inhibiting aromatic compounds UNIVERSITE PAUL SABATIER TOULOUSE III (FR) 2007-02-22 US disclosed
EP-1641807-A2 AROMATIC COMPOUNDS AS ALDOLASE INHIBITORS UNIVERSITE PAUL SABATIER TOULOUSE III (FR) 2006-04-05 EP disclosed
WO-2005012313-A2 ALDOLASE-INHIBITING AROMATIC COMPOUNDS UNIVERSITE PAUL SABATIER TOULOUSE III (FR) 2005-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043002-A1 Aldolase-inhibiting aromatic compounds ALDOA, DERA, AKR1B1 ESR1 2320/4885ESR2 1901/4885ERN1 2031/4885
US-20090137532-A1 Aldolase-inhibiting aromatic compounds ALDOA, DERA, AKR1B1 ESR1 2320/4885ESR2 1901/4885ERN1 2031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.